Epimeron, a company incorporated under the laws of Alberta, is working to enable the commercialization of high-value bioproducts by making key discoveries in plant genomics for Epimeron's synthetic biology partners. At Epimeron, newly discovered genetic elements and biochemical strategies are translated into the appropriate commercial host organism. Epimeron seeks to partner and work together to enhance the success of manufacturing programs. The current directors and officers of Epimeron are: Dr. Joseph Tucker (Chief Executive Officer and Co-Founder), Dr. Peter Facchini (Chief Scientific Officer and Co-Founder), Dr. Jillian Hagel and (Chief Operating Officer and Co-Founder). As of the date of this press release, 549,001 Epimeron Shares and 207,500 stock options are issued and outstanding. In connection with the Transaction, all outstanding stock options will be exercised.
View Top Employees from Epimeron Inc.Website | http://www.epimeron.com |
Revenue | $5 million |
Employees | View employees |
Address | Ste. A 5799 Third St. S.E, Calgary, Alberta T2H 1K1, CA |
Industry | Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Epimeron Inc. employee's phone or email?
The Epimeron Inc. annual revenue was $5 million in 2024.
Epimeron Inc. is based in Calgary, Alberta.
The NAICS codes for Epimeron Inc. are [3254, 32, 325].
The SIC codes for Epimeron Inc. are [283, 28].